The payment is scheduled for November 16, 2026, for shareholders of record as of the close of business on October 15. This announcement follows Abbott’s established history of financial reliability, characterized by 54 consecutive years of annual dividend increases. Such longevity has cemented the company's status as a member of the S&P 500 Dividend Aristocrats Index, a designation reserved for firms that have raised their payouts for at least 25 straight years.

Headquartered in Abbott Park, Illinois, the company continues to focus on its diverse portfolio spanning diagnostics, medical devices, nutritionals, and branded generic medicines. With a workforce of 122,000 employees operating across 160 countries, the firm remains a central player in the global healthcare sector, balancing long-term capital returns with the development of its life-changing technologies.